2019-2021年单味药治疗类风湿关节炎的患者临床信息数据

2019-2021年单味药治疗类风湿关节炎的患者临床信息数据：本数据集收集了以潜在雷公藤优势人群——围或绝经期女性为研究对象，采用多中心、随机、双盲的疗效比较研究的患者的临床信息数据，用来作为雷公藤提取物治疗RA的方案优化提供高级别循证医学证据的一部分。Clinical Information Data of Patients with Rheumatoid Arthritis Treated with Single Chinese Herb from 2019 to 2021: This dataset collects clinical information of patients from a multi-center, randomized, double-blind comparative efficacy study, where the subjects are potential optimal population for Tripterygium wilfordii—peri- or post-menopausal women. It serves as part of the high-level evidence-based medical evidence to support the optimization of treatment regimens for RA using Tripterygium wilfordii extract.